Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Burger

Showing results (271-280 of 342) with videos related to

Pageof 35
Sort By:
European Urology Oncology|December 11, 2025
Benchmarking Large Language Models Against Multidisciplinary Tumor Boards in Urological Oncology: Results from the Blinded, Prospective CONCORDIA StudyEmily Rinderknecht, Maximilian Haas, Marco J Schnabel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2009
Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysisPeter J Wild, Thomas Fuchs, Robert Stoehr, et al.
European Urology Focus|August 1, 2018
Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?Marko Babjuk, Maximilian Burger, Eva M Compérat, et al.
European Urology|August 25, 2019
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 UpdateMarko Babjuk, Maximilian Burger, Eva M Compérat, et al.
European Urology|September 13, 2021
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)Marko Babjuk, Maximilian Burger, Otakar Capoun, et al.
Scientific Reports|September 18, 2023
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)Johannes Breyer, Markus Eckstein, Danijel Sikic, et al.
Urologic Oncology|October 12, 2010
Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinomaHans-Martin Fritsche, Giacomo Novara, Maximilian Burger, et al.
The Journal of Urology|February 26, 2013
Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk modelMatthias May, Vincenzo Ficarra, Shahrokh F Shariat, et al.
European Urology Focus|November 21, 2017
Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic ReviewBenoit Peyronnet, Thomas Seisen, Jose-Luis Dominguez-Escrig, et al.
Urology|June 21, 2021
Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor TherapyKarl H Tully, Hendrik Jütte, Ralph M Wirtz, et al.
Pageof 35

Showing results (271-280 of 342) with videos related to

Sort By:
Pageof 35
European Urology Oncology|December 11, 2025
Benchmarking Large Language Models Against Multidisciplinary Tumor Boards in Urological Oncology: Results from the Blinded, Prospective CONCORDIA StudyEmily Rinderknecht, Maximilian Haas, Marco J Schnabel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2009
Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysisPeter J Wild, Thomas Fuchs, Robert Stoehr, et al.
European Urology Focus|August 1, 2018
Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?Marko Babjuk, Maximilian Burger, Eva M Compérat, et al.
European Urology|August 25, 2019
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 UpdateMarko Babjuk, Maximilian Burger, Eva M Compérat, et al.
European Urology|September 13, 2021
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)Marko Babjuk, Maximilian Burger, Otakar Capoun, et al.
Scientific Reports|September 18, 2023
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)Johannes Breyer, Markus Eckstein, Danijel Sikic, et al.
Urologic Oncology|October 12, 2010
Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinomaHans-Martin Fritsche, Giacomo Novara, Maximilian Burger, et al.
The Journal of Urology|February 26, 2013
Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk modelMatthias May, Vincenzo Ficarra, Shahrokh F Shariat, et al.
European Urology Focus|November 21, 2017
Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic ReviewBenoit Peyronnet, Thomas Seisen, Jose-Luis Dominguez-Escrig, et al.
Urology|June 21, 2021
Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor TherapyKarl H Tully, Hendrik Jütte, Ralph M Wirtz, et al.
Pageof 35